Rationale, design and pilot feasibility results of a smartphone-assisted, mindfulness-based intervention for smokers with mood disorders: Project mSMART MIND.
Study Goal
The researchers aimed to develop and test a smartphone-assisted mindfulness smoking cessation intervention (SMI-CM) combined with contingency management for smokers receiving outpatient psychiatric treatment.
Results Summary
The pilot feasibility study showed high acceptability and satisfaction, with participants practicing mindfulness 3.4 times/day, completing 72.3% of EMA reports, and rating mindfulness as helpful for mood management and smoking cessation (average ratings of 4.50/5).
Population
Smokers receiving outpatient treatment for mood disorders.
Effective Dosage
Mindfulness practiced ≥3 minutes, prompted 5 times/day.
Duration
Not specified in the abstract.
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
smartphone-assisted mindfulness smoking cessation intervention with contingency management (SMI-CM) | increase | acceptability and satisfaction | participants in the pilot feasibility study | high levels | showed high levels of acceptability and satisfaction | #1 |
smartphone-assisted mindfulness smoking cessation intervention with contingency management (SMI-CM) | increase | mindfulness practice frequency | participants in the pilot feasibility study | 3.4 times/day (≥3min) | practiced mindfulness an average of | #2 |
smartphone-assisted mindfulness smoking cessation intervention with contingency management (SMI-CM) | increase | prompted EMA reports | participants in the pilot feasibility study | 72.3% | completed | #3 |
smartphone-assisted mindfulness smoking cessation intervention with contingency management (SMI-CM) | increase | requested CO videos | participants in the pilot feasibility study | 68.0% | submitted | #4 |
smartphone-assisted mindfulness smoking cessation intervention with contingency management (SMI-CM) | increase | program helpfulness | participants in the pilot feasibility study | M=4.85/5 | was helpful overall | #5 |
daily mindfulness practice | increase | mood management helpfulness | participants in the pilot feasibility study | Ms=4.50/5 | was helpful for managing mood | #6 |
daily mindfulness practice | increase | smoking cessation helpfulness | participants in the pilot feasibility study | Ms=4.50/5 | was helpful for quitting smoking | #7 |
BACKGROUND: Although individuals with psychiatric disorders are disproportionately affected by cigarette smoking, few outpatient mental health treatment facilities offer smoking cessation services. In this paper, we describe the development of a smartphone-assisted mindfulness smoking cessation intervention with contingency management (SMI-CM), as well as the design and methods of an ongoing pilot randomized controlled trial (RCT) targeting smokers receiving outpatient psychiatric treatment. We also report the results of an open-label pilot feasibility study. METHODS: In phase 1, we developed and pilot-tested SMI-CM, which includes a smartphone intervention app that prompts participants to practice mindfulness, complete ecological momentary assessment (EMA) reports 5 times per day, and submit carbon monoxide (CO) videos twice per day. Participants earned incentives if submitted videos showed CO≤6ppm. In phase 2, smokers receiving outpatient treatment for mood disorders are randomized to receive SMI-CM or enhanced standard treatment plus non-contingent CM (EST). RESULTS: The results from the pilot feasibility study (N=8) showed that participants practiced mindfulness an average of 3.4times/day (≥3min), completed 72.3% of prompted EMA reports, and submitted 68.0% of requested CO videos. Participants reported that the program was helpful overall (M=4.85/5) and that daily mindfulness practice was helpful for both managing mood and quitting smoking (Ms=4.50/5). CONCLUSIONS: The results from the feasibility study indicated high levels of acceptability and satisfaction with SMI-CM. The ongoing RCT will allow evaluation of the efficacy and mechanisms of action underlying SMI-CM for improving cessation rates among smokers with mood disorders.